Regnante Keith
Insider CIK 1682068 · WVE Chief Financial Officer · KROS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | A Award deriv | 2026-02-24 | 2026-02-26 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2026-02-18 | 2026-02-20 | 4,739 | $16.35 | $77.5K | 39,261 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2025-02-18 | 2025-02-19 | 44,000 | — | $0 | 44,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2024-01-04 | 2025-01-24 | 40,000 | $16.00 | $640.0K | 40,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2024-01-04 | 2025-01-24 | 40,000 | $45.29 | $1.81M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2024-01-04 | 2024-01-08 | 40,000 | — | $0 | 53,622 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2023-11-04 | 2024-01-08 | 40,000 | $45.29 | $1.81M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2023-11-04 | 2024-01-08 | 40,000 | $16.00 | $640.0K | 40,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2023-06-09 | 2023-06-12 | 20,000 | — | $0 | 93,622 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2023-06-09 | 2023-06-12 | 15,993 | $45.03 | $720.2K | 4,007 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2023-06-09 | 2023-06-12 | 1,428 | $46.46 | $66.3K | 2,579 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2023-06-09 | 2023-06-12 | 2,579 | $47.25 | $121.9K | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2023-06-09 | 2023-06-12 | 20,000 | $16.00 | $320.0K | 20,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2023-06-08 | 2023-06-12 | 20,000 | — | $0 | 113,622 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2023-06-08 | 2023-06-12 | 20,000 | $16.00 | $320.0K | 20,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2023-06-08 | 2023-06-12 | 17,301 | $47.66 | $824.6K | 2,699 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2023-06-08 | 2023-06-12 | 2,699 | $48.65 | $131.3K | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2022-01-21 | 2022-01-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2021-01-10 | 2021-01-12 | 49,150 | — | $0 | 49,150 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2020-04-07 | 2020-04-08 | 18,430 | — | $0 | 18,430 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2020-04-07 | 2020-04-08 | 133,622 | — | $0 | 133,622 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award | 2019-03-07 | 2019-03-11 | 13,500 | — | $0 | 29,186 | SEC↗ |
| WVE Wave Life Sciences Ltd. | S Sale | 2019-02-19 | 2019-02-21 | 1,298 | $36.84 | $47.8K | 15,686 | SEC↗ |
| WVE Wave Life Sciences Ltd. | M Exercise deriv | 2018-09-24 | 2018-09-26 | 29,500 | — | $0 | 90,500 | SEC↗ |
| WVE Wave Life Sciences Ltd. | M Exercise | 2018-09-24 | 2018-09-26 | 29,500 | $20.89 | $616.3K | 46,484 | SEC↗ |
| WVE Wave Life Sciences Ltd. | S Sale | 2018-09-24 | 2018-09-26 | 29,500 | $55.00 | $1.62M | 16,984 | SEC↗ |
| WVE Wave Life Sciences Ltd. | S Sale | 2018-02-16 | 2018-02-21 | 316 | $51.85 | $16.4K | 16,984 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2018-01-23 | 2018-01-25 | 26,000 | — | $0 | 26,000 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award | 2018-01-23 | 2018-01-25 | 13,000 | — | $0 | 17,300 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2017-01-25 | 2017-01-27 | 8,600 | — | $0 | 8,600 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award | 2017-01-25 | 2017-01-27 | 4,300 | — | $0 | 4,300 | SEC↗ |
| WVE Wave Life Sciences Ltd. | A Award deriv | 2016-08-16 | 2016-08-17 | 120,000 | — | $0 | 120,000 | SEC↗ |